Journal article
Structural modeling defines transmembrane residues in ADAM17 that are crucial for Rhbdf2-ADAM17-dependent proteolysis
Journal of cell science, Vol.130(5), pp.868-878
03/01/2017
DOI: 10.1242/jcs.196436
PMCID: PMC5358332
PMID: 28104813
Abstract
A disintegrin and metalloproteinase 17 (ADAM17) controls the release of the pro-inflammatory cytokine tumor necrosis factor α (TNFα, also known as TNF) and is crucial for protecting the skin and intestinal barrier by proteolytic activation of epidermal growth factor receptor (EGFR) ligands. The seven-membrane-spanning protein called inactive rhomboid 2 (Rhbdf2; also known as iRhom2) is required for ADAM17-dependent TNFα shedding and crosstalk with the EGFR, and a point mutation (known as sinecure, sin) in the first transmembrane domain (TMD) of Rhbdf2 (Rhbdf2
) blocks TNFα shedding, yet little is known about the underlying mechanism. Here, we used a structure-function analysis informed by structural modeling to evaluate the interaction between the TMD of ADAM17 and the first TMD of Rhbdf2, and the role of this interaction in Rhbdf2-ADAM17-dependent shedding. Moreover, we show that double mutant mice that are homozygous for
and lack
closely resemble
double knockout mice, highlighting the severe functional impact of the
mutation on ADAM17 during mouse development. Taken together, these findings provide new mechanistic and conceptual insights into the critical role of the TMDs of ADAM17 and Rhbdf2 in the regulation of the ADAM17 and EGFR, and ADAM17 and TNFα signaling pathways.
Details
- Title: Subtitle
- Structural modeling defines transmembrane residues in ADAM17 that are crucial for Rhbdf2-ADAM17-dependent proteolysis
- Creators
- Xue Li - Dept. of Biochemistry, Cellular and Molecular Biology, Weill Cornell Medicine, New York, NY 10021, USAThorsten Maretzky - Arthritis and Tissue Degeneration Program, Hospital for Special Surgery, New York, NY 10021, USAJose Manuel Perez-Aguilar - IBM Thomas J. Watson Research Center, Yorktown Heights, New York, NY 10598, USASébastien Monette - Tri-Institutional Laboratory of Comparative Pathology, Sloan-Kettering Institute, New York, NY 10021 USAGisela Weskamp - Arthritis and Tissue Degeneration Program, Hospital for Special Surgery, New York, NY 10021, USASylvain Le Gall - Arthritis and Tissue Degeneration Program, Hospital for Special Surgery, New York, NY 10021, USABruce Beutler - Center for the Genetics of Host Defense, UT Southwestern Medical Center, Dallas, TX 75390, USAHarel Weinstein - Department of Physiology, Biophysics and Systems Biology, Weill Cornell Medicine, New York, NY 10021, USACarl P Blobel - Institute for Advanced Study, Technical University Munich, Garching 85748, Germany
- Resource Type
- Journal article
- Publication Details
- Journal of cell science, Vol.130(5), pp.868-878
- DOI
- 10.1242/jcs.196436
- PMID
- 28104813
- PMCID
- PMC5358332
- ISSN
- 0021-9533
- eISSN
- 1477-9137
- Grant note
- R01 GM064750 / NIGMS NIH HHS U54 GM087519 / NIGMS NIH HHS P01 DA012408 / NIDA NIH HHS P30 CA008748 / NCI NIH HHS
- Language
- English
- Date published
- 03/01/2017
- Academic Unit
- Internal Medicine
- Record Identifier
- 9984094378002771
Metrics
13 Record Views